ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

Regeneron at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Regeneron brings 10 presentations to ASHG 2026 in Montréal, and exhibits at Booth 507. Its ASHG 2026 program centres on medicines for serious diseases, spanning biologics, genetic medicines and cell therapies. Its presentations include imaging-based genetic discovery in 95,000 UK Biobank participants and protective diabetes variants in 132,045 South Asians.

OrganizationASHG 2026 Attendance
Regeneron
Tarrytown, New York
1 Employee · 1 Senior Manager, RGC · 1 Statistical Geneticist · 1 SVP and Chief Genomics and Data Sciences Officer · 1 other presenter
Public company~15,400 people
Regeneron invents, develops, and commercializes medicines for serious diseases. Its work spans biologics, genetic medicines, and cell therapies.
Won FDA approval for Pasatru, the first treatment for a rare bone-growth disorder called FOP, adding a new rare-disease product.
›
Won FDA approval for Pasatru, the first treatment for a rare bone-growth disorder called FOP, adding a new rare-disease product.
2026-08 · source
Launched a research collaboration with Parabilis Medicines to develop antibody-peptide conjugate therapies, expanding its drug-discovery pipeline.
2026-05 · source
Agreed to provide its newly approved genetic-hearing-loss gene therapy Otarmeni for free in the US, expanding patient access.
2026-04 · source
Source: company newsroom
Q2 2026 revenue $4.3B, up 17% YoY
›
2026 guidance includes R&D spend of $6.5-6.635 billion and SG&A of $2.83-2.96 billion. · 2026-07-30
“Second quarter 2026 revenues increased 17% to $4.3 billion versus second quarter 2025; GAAP R&D $6.500–$6.635 billion”
Source: results release
Currently hiring: 662 open roles
›
Source: careers page
Booth
Exhibiting at Booth 507 · Regeneron Genetics Center
Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm
Poster
Wed Oct 21
2:30 pm
★ Reviewers’ Choice
Systematic extraction of 4,434 imaging-derived phenotypes in 95,000 UK Biobank participants drives genetic discovery and validation
Complex traitsLarge-scale biobanksRare variantsIdentification of disease genes
Poster
Wed Oct 21
2:30 pm
★ Reviewers’ Choice
Exome-Wide Association Study of Type 2 Diabetes in 132,045 South Asians reveals Population-Enriched Protective Variants and Novel Therapeutic Targets
Collaborators: National Heart Foundation Hospital & Research Institute, Bangladesh Medical University +4 more
DiabetesLarge-scale biobanksRare variantsGenomics
Poster
Thu Oct 22
4:15 pm
Poster
Fri Oct 23
2:30 pm
SBAT-REMETA: Combining rare-variant burden scores from summary statistics boosts gene discovery in multi-cohort studies
Statistical geneticsRare variantsLarge-scale biobanksGenome-wide association study
Poster
Fri Oct 23
2:30 pm
Whole-Exome Sequencing for Severe Inflammatory Bowel Disease: Genetic Architecture and Emerging Candidate Genes
Collaborators: Boston Children's Hospital
Clinical geneticsDiagnosticsGastrointestinal systemImmune system
Poster
Fri Oct 23
2:30 pm
Identifying genetic variants with large effects on risk of depression using severe phenotypes
DepressionPolygenic risk scorePsychiatric geneticsGenetic epidemiology
Poster
Fri Oct 23
2:30 pm
Poster
Fri Oct 23
2:30 pm
Ancestry-specific associations with adult height in 2.1 million diverse exomes
Collaborators: University of Oxford, Universidad Nacional Autónoma de México +6 more
Complex traitsExome/genome sequencingRare variantsSkeletal system
Talk
Sat Oct 24
8:15 am
A distinct subset of autoimmune diseases defined by profound co-prevalence and genetic risk association with the IL12 pathway
Collaborators: University of Pittsburgh, Skåne University Hospital +2 more
Autoimmune disorderIdentification of disease genesGenome-wide association studyRare variants
Session
Sat Oct 24
11:15 am
Globalizing Human Genetics: From Discovery Through Implementation
1 invited symposium speaker

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Regeneron

Tell us what you sell and we’ll find the people at Regeneron most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction